Oligodendroglioma - 253 Studies Found
Completed |
: Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma :
: |
Suspended |
: Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme :
: |
Active, not recruiting |
: Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor :
|
Active, not recruiting |
: Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor :
|
Terminated |
: Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas :
|
Completed |
: Research of Molecular and Metabolic Markers in Oligodendrogliomas Comparatively to Other Brain Tumours : Oligodendrogliomas : 2005-09-13 |
Recruiting |
: Safety and Efficacy of PD0332991 (Palbociclib), a Cyclin-dependent Kinase 4 and 6 Inhibitor, in Patients With Oligodendroglioma or Recurrent Oligoastrocytoma Anaplastic With the Activity of the Protein RB Preserved :
: 2015-08-18 : Drug: Palbociclib Palbociclib will be administered orally at a dose of 125 mg/day, until disease progres |
Completed |
: Temozolomide in Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: Single-arm, Phase II Trial :
: 2013-04-29 : Drug: Temozolomide Temozolomide 200 mg/m2/d in a fasting state for 5 consecutive days (1,000 mg/m2 per 2 |
Completed |
: Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed Oligoastrocytoma :
: 2006-08-08 : Drug: Temozolomide p.o.(by mouth), 150 mg/m2/d x days 1-7 |
Terminated |
: Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas :
|